Medicine
Olinvyk 2 mg/2 mL injection
Olinvyk 2 mg/2 mL injection is a prescription medicine containing Oliceridine for intravenous use, marketed by Trevena, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at controlled room temperature 20°-25°C…
Key facts
- Active ingredient (INN)
- Oliceridine
- Brand
- Olinvyk
- Strength
- 2 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials of 2 mL
- Marketing authorisation holder
- Trevena
- Manufacturer
- Trevena
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at controlled room temperature 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 August 2020
- Identifiers
- RxCUI 2392234, 2392239, 2392242 +3DailyMed set ID ce167984-8b9d-40b7-84ce-d0f33fff1eaaNDC 71308-021Application NDA210730
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 71308-021-10 | Trevena | 7 August 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 August 2020 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Oliceridine
Clinical summary
Oliceridine is a prescription medicine indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. It is available as injection for intravenous use. MedsAcross supplies Oliceridine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OliceridineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OLINVYK prescribing information (Trevena) · U.S. National Library of Medicine, DailyMed
Need Olinvyk 2 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.